Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
Actual shortage: | 237 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2778 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TRYPTOPHAN | 500MG | CAPSULE | Resolved | 2021-11-29 | 2021-12-09 | 150178 |
APO-RIVASTIGMINE | 6MG | CAPSULE | Resolved | 2021-12-03 | 2021-12-13 | 150440 |
APO-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2022-01-07 | 2022-03-28 | 152295 |
APO-GABAPENTIN | 300MG | CAPSULE | Resolved | 2022-01-07 | 2022-01-31 | 152310 |
APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2022-01-21 | 2022-04-01 | 153262 |
FLUCONAZOLE 150 | 150MG | CAPSULE | Resolved | 2022-02-11 | 2022-04-01 | 154746 |
APO-TRYPTOPHAN | 500MG | CAPSULE | Resolved | 2022-02-22 | 2022-03-09 | 155365 |
APO-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2022-02-25 | 2022-03-29 | 155597 |
APO-ATOMOXETINE | 60MG | CAPSULE | Resolved | 2022-02-25 | 2022-04-01 | 155600 |
APO-METRONIDAZOLE | 500MG | CAPSULE | Resolved | 2022-04-08 | 2022-05-14 | 158364 |
APO-PREGABALIN | 50MG | CAPSULE | Resolved | 2022-04-08 | 2022-05-13 | 158367 |
APO-TRYPTOPHAN | 500MG | CAPSULE | Resolved | 2022-05-06 | 2022-06-17 | 160144 |
APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2022-05-27 | 2022-09-30 | 161448 |
APO-FLUOXETINE | 20MG | CAPSULE | Resolved | 2022-09-16 | 2022-09-30 | 169510 |
APO-VALPROIC ACID | 250MG | CAPSULE | Resolved | 2022-09-23 | 2023-05-12 | 170115 |
APO-FLUOXETINE | 20MG | CAPSULE | Resolved | 2022-11-04 | 2023-03-02 | 173815 |
APO-DABIGATRAN | 110MG | CAPSULE | Resolved | 2022-11-20 | 2023-01-20 | 175318 |
APO-CEFADROXIL | 500MG | CAPSULE | Resolved | 2022-11-20 | 2022-12-23 | 175327 |
APO-RIVASTIGMINE | 1.5MG | CAPSULE | Resolved | 2022-11-27 | 2023-03-09 | 175898 |
APO-AMOXI | 500MG | CAPSULE | Resolved | 2022-11-27 | 2023-01-06 | 175904 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-LOPERAMIDE | 2MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4930 |
APO-SOTALOL | 80MG | TABLET | Discontinued | 2017-03-31 | 2018-12-07 | 4936 |
APO-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4965 |
APO-OLANZAPINE | 5.0MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4968 |
APO-SOTALOL | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
APO-TERAZOSIN | 2MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4974 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40781 |
APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40784 |
APO-METFORMIN | 500MG | TABLET | Discontinued | 2018-02-23 | 2018-11-26 | 40790 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40811 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40814 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40823 |